Pyridine

Pyridine

SCHEMBL4636073

OCl.c1ccncc1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL8733420 0.96 NAPRT (0.69)
Tetrachloroethylene SCHEMBL3073798 0.93 TSHR (0.64)
Pyridine SCHEMBL29072605 0.92
Pyridine SCHEMBL28067297 0.91 NAPRT (0.90)
Pyridine SCHEMBL6532110 0.91
Pyridine SCHEMBL31396433 0.91
Pyridine SCHEMBL936385 0.89 NAPRT (0.60)
Pyridine SCHEMBL9851406 0.89 NAPRT (0.60)
Pyridine SCHEMBL6730524 0.89 NAPRT (0.60)
Pyridine SCHEMBL28910607 0.87 NAPRT (0.82)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108676019-A A kind of trichloropyridine alcohol-metal complex 广西师范学院 2018-10-19 CN claimed
EP-1136123-B1 Catalytic composition and catalytic process of dimerisation, codimerisation and oligomerisation of olefins INST FRANCAIS DU PETROLE (FR) 2005-05-25 EP claimed
US-6576724-B2 1) Nickel compound that contains at least one heterocyclic mono- or bicarbene ligand (especially imidazolydiylidene), 2) quaternary ammonium halide and/or quaternary phosphonium halide, 3) aluminum halide INSTITUT FRANCAIS DU PETROLE (FR) 2003-06-10 US claimed
US-20010049398-A1 Catalytic composition and process for the catalysis of dimerization codimerization and oligomerization of olefins INSTITUT FRANCAIS DU PETROLE (FR) 2001-12-06 US claimed
CN-116999573-A Antibody-drug conjugate, preparation method thereof, pharmaceutical composition and application thereof in preparation of drugs for treating tumors 第一三共株式会社 2023-11-07 CN disclosed
CN-116999572-A Antibody-drug conjugate, pharmaceutical composition and application thereof in preparation of drugs for treating tumors 第一三共株式会社 2023-11-07 CN disclosed
CN-117003875-A Antibody or functional fragment thereof, polynucleotide, expression vector, host cell, sugar chain reconstruction antibody, pharmaceutical composition and application 第一三共株式会社 2023-11-07 CN disclosed
CN-111164208-B Antibody-pyrrolobenzodiazepine derivative conjugates 第一三共株式会社 2023-08-04 CN disclosed
CN-210707989-U Negative-pressure dust suppression device for chlorpyrinol packaging 内蒙古华天制药有限公司 2020-06-09 CN disclosed
US-20080287434-A1 New amino-alkyl-amide derivatives as CCR3 receptor ligands SANOFI-AVENTIS (FR) 2008-11-20 US disclosed
EP-1931620-A1 AMINO-ALKYL-AMIDE DERIVATIVES AS CCR3 RECEPTOR LIQUIDS Sanofi-Aventis (FR) 2008-06-18 EP disclosed
WO-2007034252-A1 AMINO-ALKYL-AMIDE DERIVATIVES AS CCR3 RECEPTOR LIQUIDS SANOFI-AVENTIS (FR) 2007-03-29 WO disclosed
US-4607052-A Triglycerides, dietetic and therapeutical applications and compositions containing them ROUSSEL-UCLAF (FR) 1986-08-19 US disclosed
US-4508658-A Pentahalophenyl ester of cyanoacetic acid derivatives CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) 1985-04-02 US disclosed
US-4436749-A CARDIOVASCULAR DISORDERS PIERRE FABRE S.A. (FR) 1984-03-13 US disclosed
US-4324903-A Malonic esters CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) 1982-04-13 US disclosed
US-4289894-A INTERMEDIATES IN MANUFACTURE OF PENICILLINS CHINOIN GYOGYSZER ES VEGYLSZETI TERMEKEK GYARA R.T. (HU) 1981-09-15 US disclosed
US-4258202-A INSECTICIDES OF THE PYRETHROID TYPE MONTEDISON S.P.A. (IT) 1981-03-24 US disclosed
US-4182892-A CHEMICAL INTERMEDIATES FOR ACYLATION OF PEPTIDES OR PENAM-RING OR CEPHAM-RING CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT (HU) 1980-01-08 US disclosed
US-4015017-A Certain biphenyl derivatives used to treat disorders caused by increased capillary permeability LABORATOIRES PHARMASCIENCE (FR) 1977-03-29 US disclosed